These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26774838)

  • 1. The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.
    Denisov IG; Mak PJ; Grinkova YV; Bastien D; Bérubé G; Sligar SG; Kincaid JR
    J Inorg Biochem; 2016 May; 158():77-85. PubMed ID: 26774838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Insights into the Heterotropic Allosteric Mechanism in Cytochrome P450 3A4-Mediated Midazolam Metabolism.
    Fu T; Zhang H; Zheng Q
    J Chem Inf Model; 2022 Nov; 62(22):5762-5770. PubMed ID: 36342224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.
    Denisov IG; Grinkova YV; McLean MA; Camp T; Sligar SG
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase.
    Ducharme J; Sevrioukova IF; Thibodeaux CJ; Auclair K
    Biochemistry; 2021 Jul; 60(28):2259-2271. PubMed ID: 34196520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probe Substrate Dependencies in CYP3A4 Allosteric Inhibition: A Novel Molecular Mechanism Involving F-F' Loop Perturbations.
    Wei W; Tang LWT; Verma RK; Fan H; Chan ECY
    J Chem Inf Model; 2024 Mar; 64(6):2058-2067. PubMed ID: 38457234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions among cytochromes P450 in microsomal membranes: oligomerization of cytochromes P450 3A4, 3A5, and 2E1 and its functional consequences.
    Davydov DR; Davydova NY; Sineva EV; Halpert JR
    J Biol Chem; 2015 Feb; 290(6):3850-64. PubMed ID: 25533469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the role of residue Phe108 of cytochrome P450 3A4 in allosteric effects of midazolam metabolism.
    Fu T; Zhang H; Zheng Q
    Phys Chem Chem Phys; 2024 Mar; 26(11):8807-8814. PubMed ID: 38421040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the molecular and mechanistic basis for the regioselective metabolism of midazolam by cytochrome P450 3A4.
    Fu T; Zheng Q; Zhang H
    Phys Chem Chem Phys; 2022 Apr; 24(14):8104-8112. PubMed ID: 35319551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the Ligand-Binding Sites of CYP3A4 by Molecular Dynamics Simulations with Solvent Probes.
    Feng Y; Gong C; Zhu J; Liu G; Tang Y; Li W
    J Chem Inf Model; 2024 Apr; 64(8):3451-3464. PubMed ID: 38593186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative C
    Paquin A; Oufqir Y; Sevrioukova IF; Reyes-Moreno C; Bérubé G
    Eur J Med Chem; 2021 Aug; 220():113496. PubMed ID: 33933755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Small-Molecule Bioconjugation and Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to Expose Allostery: the Case of Human Cytochrome P450 3A4.
    Ducharme J; Polic V; Thibodeaux CJ; Auclair K
    ACS Chem Biol; 2021 May; 16(5):882-890. PubMed ID: 33913317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal Structure of CYP3A4 Complexed with Fluorol Identifies the Substrate Access Channel as a High-Affinity Ligand Binding Site.
    Sevrioukova IF
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midazolam as a Probe for Drug-Drug Interactions Mediated by CYP3A4: Homotropic Allosteric Mechanism of Site-Specific Hydroxylation.
    Denisov IG; Grinkova YV; Camp T; McLean MA; Sligar SG
    Biochemistry; 2021 Jun; 60(21):1670-1681. PubMed ID: 34015213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodisc-embedded cytochrome P450 P3A4 binds diverse ligands by distributing conformational dynamics to its flexible elements.
    Paço L; Hackett JC; Atkins WM
    J Inorg Biochem; 2023 Jul; 244():112211. PubMed ID: 37080138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced Fit Describes Ligand Binding to Membrane-Associated Cytochrome P450 3A4.
    Sweeney DT; Zárate-Pérez F; Stokowa-Sołtys K; Hackett JC
    Mol Pharmacol; 2023 Oct; 104(4):154-163. PubMed ID: 37536953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors.
    Kiani YS; Ranaghan KE; Jabeen I; Mulholland AJ
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength.
    Samuels ER; Sevrioukova IF
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7.
    Sevrioukova IF
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ir(III)-Based Agents for Monitoring the Cytochrome P450 3A4 Active Site Occupancy.
    Denison M; Steinke SJ; Majeed A; Turro C; Kocarek TA; Sevrioukova IF; Kodanko JJ
    Inorg Chem; 2022 Sep; 61(35):13673-13677. PubMed ID: 35994607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.